ORLANDONI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 2.780
EU - Europa 1.288
AS - Asia 1.256
SA - Sud America 300
AF - Africa 77
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.705
Nazione #
US - Stati Uniti d'America 2.732
SG - Singapore 459
UA - Ucraina 229
VN - Vietnam 225
BR - Brasile 222
CN - Cina 219
RU - Federazione Russa 213
IT - Italia 160
SE - Svezia 128
DE - Germania 125
IE - Irlanda 115
TR - Turchia 105
HK - Hong Kong 89
DK - Danimarca 87
FR - Francia 84
FI - Finlandia 73
KR - Corea 48
CI - Costa d'Avorio 38
GB - Regno Unito 37
AR - Argentina 25
BD - Bangladesh 22
MX - Messico 20
CA - Canada 17
CO - Colombia 16
IN - India 16
ZA - Sudafrica 15
EC - Ecuador 11
JP - Giappone 11
IQ - Iraq 10
MA - Marocco 10
ID - Indonesia 7
UZ - Uzbekistan 7
NL - Olanda 6
PK - Pakistan 6
PY - Paraguay 6
VE - Venezuela 6
BE - Belgio 5
CL - Cile 5
ES - Italia 5
MY - Malesia 5
PL - Polonia 5
OM - Oman 4
PE - Perù 4
SA - Arabia Saudita 4
TN - Tunisia 4
UY - Uruguay 4
AT - Austria 3
CR - Costa Rica 3
DZ - Algeria 3
KZ - Kazakistan 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
EG - Egitto 2
JO - Giordania 2
LT - Lituania 2
PA - Panama 2
PS - Palestinian Territory 2
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
TO - Tonga 1
TT - Trinidad e Tobago 1
WS - Samoa 1
Totale 5.705
Città #
Ashburn 487
Singapore 296
Chandler 225
Jacksonville 225
Fairfield 191
Dallas 168
San Jose 152
Dublin 115
Boardman 97
Wilmington 96
Hong Kong 84
Seattle 84
Woodbridge 82
Ho Chi Minh City 78
Houston 71
New York 69
Beijing 63
Moscow 58
Hanoi 55
Ann Arbor 50
Cambridge 50
Lawrence 45
Princeton 45
San Mateo 45
Turin 45
Lauterbourg 39
Abidjan 38
Los Angeles 33
The Dalles 33
Hefei 32
São Paulo 25
Buffalo 23
Munich 21
Orem 19
Turku 19
Milan 17
San Diego 16
Des Moines 15
Santa Clara 14
Johannesburg 11
Da Nang 10
London 10
Chicago 9
Denver 9
Helsinki 9
Shanghai 9
Tokyo 9
Centro 8
Izmir 8
Falls Church 7
Guangzhou 7
Montreal 7
Nuremberg 7
Tashkent 7
Atlanta 6
Brasília 6
Chennai 6
Council Bluffs 6
Haiphong 6
Miano 6
Rio de Janeiro 6
Wuhan 6
Brooklyn 5
Brussels 5
Can Tho 5
Columbus 5
Guayaquil 5
Manchester 5
Mexico City 5
Naples 5
Phoenix 5
Poplar 5
Stockholm 5
Warsaw 5
Amsterdam 4
Baghdad 4
Bogotá 4
Boston 4
Guarulhos 4
Istanbul 4
Montevideo 4
Norwalk 4
Paris 4
Wuxi 4
Bauru 3
Biên Hòa 3
Bắc Ninh 3
Campinas 3
Campobasso 3
Caracas 3
Charlotte 3
Curitiba 3
Detroit 3
Dhaka 3
Indaiatuba 3
Jakarta 3
Kilburn 3
Maceió 3
Maricá 3
Medellín 3
Totale 3.643
Nome #
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 265
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 200
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 182
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 165
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 154
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 148
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 148
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 146
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 144
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 141
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 138
EFFECT OF PLATELET RICH PLASMA CONCENTRATION ON SKELETAL MUSCLE REGENERATION: AN EXPERIMENTAL STUDY 136
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 132
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 131
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 131
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 128
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 127
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 126
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 125
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 124
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 123
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 122
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 122
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 121
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 119
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 118
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 117
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 117
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 116
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 115
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 113
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. 110
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 110
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 110
Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin resistant Staphylococcus aureus. 109
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 108
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 106
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 101
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 99
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 99
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 98
Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. 97
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 94
Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis. 93
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock 87
Devices for minimally invasive liver parenchyma transection: the SICE (Italian Society of Endoscopic Surgery) Italian and International survey 45
Totale 5.760
Categoria #
all - tutte 25.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.064


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 0 0 0 0 0 33
2021/2022375 31 79 0 4 6 38 21 13 25 63 15 80
2022/2023644 65 80 53 43 49 75 0 28 158 3 76 14
2023/2024308 63 9 15 50 55 76 3 3 0 1 5 28
2024/2025793 109 52 45 36 40 54 72 40 145 35 91 74
2025/20262.225 140 246 181 235 219 144 361 233 208 167 20 71
Totale 5.760